Search or choose
Find the right test or package.
AML Risk Stratification Gene Panel
The AML risk stratification gene panel by Next-Generation Sequencing (NGS) is a groundbreaking tool in the field of acute myeloid leukemia (AML) diagnosis and treatment. This gene panel utilizes the power of NGS technology to analyze a comprehensive set of gen...
DiagnosticsLab test
Know more about this test
The AML risk stratification gene panel by Next-Generation Sequencing (NGS) is a groundbreaking tool in the field of acute myeloid leukemia (AML) diagnosis and treatment. This gene panel utilizes the power of NGS technology to analyze a comprehensive...
Understanding AML Risk Stratification Gene Panel
.
What does AML Risk Stratification Gene Panel measure?
The AML risk stratification gene panel by Next-Generation Sequencing (NGS) is a groundbreaking tool in the field of acute myeloid leukemia (AML) diagnosis and treatment. This gene panel utilizes the power of NGS technology to analyze a comprehensive set of genes associated with AML, enabling a more accurate and detailed assessment of a patient's risk profile. By examining specific genetic mutations and alterations, the panel allows for precise identification of high-risk AML patients who may require more aggressive...
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.